Use of sildenafil in a liver transplant recipient with acute pulmonary embolism
β Scribed by H. J. R. Bonatti; R. G. Sawyer; K. D. Hagspiel
- Publisher
- Blackwell Publishing
- Year
- 2010
- Tongue
- German
- Weight
- 96 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0001-544X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Coccidioidomycosis has been previously described in recipients of solid organ transplantation, especially in patients who have lived in or have visited areas endemic for Coccidioides spp. We present a case of coccidioidomycosis in a liver transplant recipient with several unique aspects, including n
Interferon alfa-2b (IFN-alpha) therapy has been shown to be effective in the treatment of viral hepatitis B (HBV) or viral hepatitis C (HCV) in patients who did not undergo transplantation. However, in allograft recipients, treatment with IFN-alpha often leads to allograft rejection. The aim of the
A 44-year-old white man was diagnosed with chronic hepatitis B in 1999 by his primary-care physician. His laboratory results were as follows: aspartate aminotransferase (AST) 144 IU/L, alanine aminotransferase (ALT) 82 IU/L, hepatitis B surface antigen (HBsAg) positive, hepatitis B e antigen (HBeAg)
In liver transplant recipients, the treatment of a biliary leak resulting from anastomotic disruption usually requires surgical intervention. However, reoperation results in significant morbidity in such patients, whose clinical status may preclude a second surgery. Restoring the integrity of a disr